Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CLDX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CLDX investment potential.

What is CLDX stock price today?

Get real-time CLDX stock price, historical data, and price charts on Financhill. Track CLDX performance with our advanced analysis tools.

Is CLDX a good investment?

Evaluate CLDX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CLDX stock?

To buy CLDX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CLDX?

View detailed market capitalization data and company valuation metrics for CLDX on our comprehensive analysis page.

What is the P/E ratio of CLDX?

Use our fundamental analysis tools to view CLDX P/E ratio and compare valuation metrics with industry peers.

What are CLDX earnings?

View CLDX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Celldex Therapeutics, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

CLDX
Celldex Therapeutics, Inc.

Last Price:

$29.61

Seasonality Move:

15.7%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

Celldex Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Celldex Therapeutics, Inc. has on average historically risen by 38.2% based on the past 39 years of stock performance.
Celldex Therapeutics, Inc. has risen higher in 11 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 28.21%
Is Celldex Therapeutics, Inc. Stock Undervalued?

The current Celldex Therapeutics, Inc. [CLDX] share price is $29.60. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Celldex Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Celldex Therapeutics, Inc. has on average historically risen by 38.2% based on the past 39 years of stock performance.

Celldex Therapeutics, Inc. Stock Rating

Sell

Celldex Therapeutics, Inc. (CLDX) is a Sell

Is Celldex Therapeutics, Inc. overpriced?

Celldex Therapeutics, Inc. has risen higher in 11 of those 39 years over the subsequent 52-week period, corresponding to a historical accuracy of 28.21%

Celldex Therapeutics, Inc. Stock Price History

Is CLDX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

celldex.com

52-Week Data

52-Week High:

29.71

52-Week Low:

14.40

Prediction Charts

Market Cap:

Price in USD:

29.60

Volume:

741.7K

Beta:

1.79

Technical Analysis

SMA50:

26.02

SMA100:

24.59

SMA200:

22.29

52-Wk Change:

11.36%

Stock Predictions

Is Celldex Therapeutics, Inc. stock public?

Yes, Celldex Therapeutics, Inc. is a publicly traded company.
What is the Celldex Therapeutics, Inc. stock quote today?

The Celldex Therapeutics, Inc. stock price is 29.60 USD today.
How to buy Celldex Therapeutics, Inc. stock online?

You can buy Celldex Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	23.47	25.56	25.62	23.47
Nov-17	25.46	26.02	26.50	25.40
Nov-18	25.58	25.59	25.99	24.92
Nov-19	25.35	24.92	25.99	24.53
Nov-20	24.93	25.07	26.10	24.74
Nov-21	24.93	25.92	26.09	24.79
Nov-24	26.08	26.33	26.63	25.06
Nov-25	26.36	26.44	26.59	25.71
Nov-26	26.27	26.80	26.82	26.02
Nov-28	26.82	27.02	27.06	26.61
Dec-1	26.60	25.93	26.73	25.69
Dec-2	26.34	26.67	27.75	25.92
Dec-3	26.82	27.81	28.49	26.68
Dec-4	27.68	29.60	29.71	27.68

Celldex Therapeutics, Inc. Earnings

Celldex Therapeutics, Inc. Earnings Report: Per Share Celldex Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Celldex Therapeutics, Inc. Forecast Revenue Growth

Celldex Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Celldex Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.22 per share, and a decrease next year of $0.83 per share.

* Celldex Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.